Table 4.
Features | AUC | 95% CI |
---|---|---|
SUVmin | 0.739 | 0.586–0.891 |
SUVmean | 0.734 | 0.585–0.884 |
SUVstd | 0.725 | 0.572–0.878 |
SUVmax | 0.758 | 0.612–0.904 |
SUVpeak | 0.733 | 0.577–0.889 |
TLG | 0.822 | 0.687–0.956 |
SHAPEvolume | 0.741 | 0.583–0.899 |
SHAPEcompacity | 0.759 | 0.607–0.911 |
GLCM_entropylog10 | 0.701 | 0.543–0.860 |
GLCM_entropylog2 | 0.703 | 0.545–0.861 |
GLRLM_HGRE | 0.730 | 0.579–0.880 |
GLRLM_SRHGE | 0.727 | 0.576–0.879 |
GLRLM_LRHGE | 0.750 | 0.601–0.899 |
GLRLM_RLNU | 0.827 | 0.700–0.964 |
GLZLM_HGZE | 0.740 | 0.590–0.890 |
GLZLM_SZHGE | 0.732 | 0.579–0.884 |
GLZLM_GLNU | 0.788 | 0.641–0.934 |
GLZLM_ZLNU | 0.725 | 0.569–0.881 |
SUV, standard uptake value; TLG, total lesion glycolysis; GLCM, gray-level co-occurrence matrix; GLRLM, gray-level run length matrix; GLZLM, gray-level zone length matrix; HGRE, high gray-level run emphasis; SRGHE, short-run high gray-level emphasis; LRHGE, long-run high gray-level emphasis; RLNU, run length non-uniformity; RP, run percentage; HGZE, high gray-level zone emphasis; SZHGE, short-zone high gray-level emphasis; GLNU, gray-level non-uniformity; ZLNU, zone length non-uniformity; AUC, area under curve; CI, confidence interval